2022 annual financial data
Enanta Pharmaceuticals 2022 Operating margin
Enanta Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -143.74%.
Operating income was -123,844,000 USD and net income was -121,755,000 USD.
Operating cash flow was -84,782,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 86,160,000 USD
- Operating income
- -123,844,000 USD
- Net income
- -121,755,000 USD
- Operating cash flow
- -84,782,000 USD